Canaccord Genuity Group reaffirmed their buy rating on shares of Allogene Therapeutics (NASDAQ:ALLO – Free Report) in a ...

Bird Construction (TSE:BDT – Free Report) had its price target decreased by Canaccord Genuity Group from C$36.00 to C$35.00 in a report released on Friday,BayStreet.CA reports. Canaccord Genuity Group ...

Peloton Interactive is on a track for growth and shares look like a buy, Canaccord analysts say. Susan Anderson and Alec Legg ...

After a period of turmoil, Peloton is “regaining its footing” and is poised to benefit as a “leader in connected fitness,” ...

Canaccord reiterates a Buy rating on PacBio (PACB) with a $3 price target following the company’s Q4 report. The firm says that although PacBio ...

Canaccord raised the firm’s price target on AxoGen (AXGN) to $26 from $22 and keeps a Buy rating on the shares. The firm said they posted ...

Fitness stock Peloton Interactive Inc (NASDAQ:PTON) is surging today, up 10.2% at $6.69 at last glance, following an upgrade ...

Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc ...

will present at the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego on Monday, March 10, 2025 at 2:30pm PT / 5:30pm ET. Management will also participate in one-on-one investor ...

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Canaccord Genuity ...

The rise in Peloton’s stock reflects investor optimism following Canaccord Genuity analyst Susan Anderson’s reassessment of the company’s prospects. Anderson cites Peloton’s position as a leader in ...